According to Pulmatrix's latest financial reports the company's current EPS (TTM) is -$4.85. In 2022 the company made an earnings per share (EPS) of -$5.46 an increase over its 2021 EPS that were of -$8.61.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.85 | -11.17% |
2022 | -$5.46 | -36.59% |
2021 | -$8.61 | -32.89% |
2020 | -$12.83 | -56.95% |
2019 | -$29.80 | -72.96% |
2018 | -$110.20 | -40.88% |
2017 | -$186.40 | -50.16% |
2016 | -$374.00 | -74.09% |
2015 | -$1,444 | 88.7% |
2014 | -$765.00 | 17.69% |
2013 | -$650.00 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Pieris Pharmaceuticals PIRS | -$0.37 | -92.37% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | -$0.27 | -94.43% | ๐บ๐ธ USA |
![]() Blueprint Medicines
BPMC | -$9.19 | 89.48% | ๐บ๐ธ USA |